Literature DB >> 8889717

Multi-drug resistant non-typhi salmonellae in Kenya.

S Kariuki1, C Gilks, J Corkill, J Kimari, A Benea, P Waiyaki, C A Hart.   

Abstract

Two methods of plasmid characterization, restriction digest patterns and incompatibility grouping, were used to study self-transmissible multi-drug resistance among non-typhi salmonellae (NTS). Resistance to ampicillin and other commonly applied beta-lactams was evaluated by iso-electric focusing and disc inactivation. Of the NTS isolated from blood, 75% were Salmonella typhimurium but those included several different phage types. Over 47% of isolates were resistant to three or more of the readily available drugs including ampicillin, cefuroxime, chloramphenicol, co-trimoxazole, streptomycin and tetracycline. Self-transferable resistance plasmids (c. 100 kb) were essentially of incompatibility group incFIIA, but their restriction fragment patterns revealed a diversity in relatedness. More than half of parent strains and their transconjugants produced beta-lactamases which co-electrophoresed with TEM-1 and OXA-1. This study has observed a disturbingly high prevalence of transmissible multi-drug resistance among NTS which are an important cause of morbidity in HIV-1 seropositive individuals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8889717     DOI: 10.1093/jac/38.3.425

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

1.  Integron- and carbenicillinase-mediated reduced susceptibility to amoxicillin-clavulanic acid in isolates of multidrug-resistant Salmonella enterica serotype typhimurium DT104 from French patients.

Authors:  L Poirel; M Guibert; S Bellais; T Naas; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Multiple outbreaks of nosocomial salmonellosis in Russia and Belarus caused by a single clone of Salmonella enterica serovar Typhimurium producing an extended-spectrum beta-lactamase.

Authors:  M Edelstein; M Pimkin; T Dmitrachenko; V Semenov; N Kozlova; D Gladin; A Baraniak; L Stratchounski
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

3.  Antibiotic resistance in Salmonella enterica serotype typhimurium.

Authors:  U Gross; H Tschäpe; I Bednarek; M Frosch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-06       Impact factor: 3.267

4.  Typing of Salmonella enterica serotype paratyphi C isolates from various countries by plasmid profiles and pulsed-field gel electrophoresis.

Authors:  S Kariuki; J Cheesbrough; A K Mavridis; C A Hart
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

5.  Analysis of plasmid and chromosomal DNA of multidrug-resistant Salmonella enterica serovar typhi from Asia.

Authors:  S Mirza; S Kariuki; K Z Mamun; N J Beeching; C A Hart
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

6.  Changes in antimicrobial resistance among Salmonella enterica Serovar typhimurium isolates from humans and cattle in the Northwestern United States, 1982-1997.

Authors:  M A Davis; D D Hancock; T E Besser; D H Rice; J M Gay; C Gay; L Gearhart; R DiGiacomo
Journal:  Emerg Infect Dis       Date:  1999 Nov-Dec       Impact factor: 6.883

7.  A review of 40 years of enteric antimicrobial resistance research in Eastern Africa: what can be done better?

Authors:  Sylvia Omulo; Samuel M Thumbi; M Kariuki Njenga; Douglas R Call
Journal:  Antimicrob Resist Infect Control       Date:  2015-01-28       Impact factor: 4.887

Review 8.  A Systematic Review of the Incidence, Risk Factors and Case Fatality Rates of Invasive Nontyphoidal Salmonella (iNTS) Disease in Africa (1966 to 2014).

Authors:  Ifeanyi Valentine Uche; Calman A MacLennan; Allan Saul
Journal:  PLoS Negl Trop Dis       Date:  2017-01-05

9.  Surveillance of antimicrobial resistance at a tertiary hospital in Tanzania.

Authors:  Bjørn Blomberg; Davis S M Mwakagile; Willy K Urassa; Samwel Y Maselle; Marcellina Mashurano; Asbjørn Digranes; Stig Harthug; Nina Langeland
Journal:  BMC Public Health       Date:  2004-10-11       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.